Records containing: Pathologic Stage IIIC Gastric Cancer AJCC v8
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-24Gastric Cancer Enhanced Recovery After Surgery Pathway
-
CLINICAL_TRIALS study record update · 2026-01-14A Phase Ib Trial of Preoperative Short-Course Chemoradiotherapy Followed by Chemotherapy for Resectable Gastric Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2026-01-12A Pilot Study of Pembrolizumab and Lenvatinib Combination Therapy in Patients With Previously Treated Advanced Gastroesophageal Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2025-12-05Remote Perioperative Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
-
CLINICAL_TRIALS study record update · 2025-08-22A Phase 2A, Dose-Finding Study of Ad5.F35-hGCC-PADRE Vaccine in Adults With Gastrointestinal Adenocarcinomas at Risk of Relapse Post Definitive Surgery and Standard Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-15Real-Time Monitoring of Chemotherapy Side Effects in Patients With Gastro-Intestinal Malignancies
-
CLINICAL_TRIALS study record update · 2025-02-07Total Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction (GEJ) and Gastric Cancers: A Pilot Trial
-
CLINICAL_TRIALS study record update · 2024-04-01Ramucirumab Plus Trifluridine/Tipiracil (TAS-102) for Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: An Investigator-Initiated, Randomized Non-Inferiority Phase 2 Study
-
CLINICAL_TRIALS study record update · 2023-11-18A Pilot Study of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastroesophageal Adenocarcinoma